Faculty
Affiliated with both the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Medicine, the Center faculty reflect the tremendous breadth and depth of human capital within the Johns Hopkins community, and represent fields of expertise ranging from pharmacovigilance to regulatory science to psychiatric pharmacoepidemiology.
If you are interested in becoming a core faculty member, please contact us.
G. Caleb Alexander, MD, MS (Co-Director)
Expertise: Drug utilization, patient-provider decision making, effects of regulatory and payment policies
Jodi Segal, MD, MPH (Co-Director)
Expertise: Pharmacoepidemiology, comparative effectiveness research, evidence-based review, advanced methods for using observational data
Gerard Anderson, PhD
Expertise: Studies of chronic conditions, comparative insurance systems in developing countries, medical education, health care payment reform, technology diffusion
Lawrence Appel, MD, MPH
Expertise: Cardiovascular disease; Kidney disease; Hypertension; Blood pressure; Nutrition; Obesity; Lifestyle modification; Behavioral interventions; Fall prevention; Clinical trials; Global prevention and control of non-communicable diseases
Jeromie Ballreich, PhD, MHS
Expertise: Health economics, cost-effectiveness analysis, US pharmaceutical policy
Michael Blaha, MD, MPH
Expertise: Cardiovascular Computed Tomography, Cardiovascular Disease, Preventive Cardiology
Joseph Coresh, MD, PhD
Expertise: Epidemiology; Cardiovascular Disease; Kidney Disease; Biomarkers; Dementia; Hearing Loss; Metabolomics; Proteomics; Genetic Epidemiology
Gerald Dal Pan, MD, MHS
Expertise: Drug surveillance and epidemiology
Maria Eng, DrPH, MPH
Expertise: Pharmaceuticals management in developing countries and underserved populations, medication access and adherence, peer education, community participation, program development and evaluation
Brian Garibaldi, MD
Expertise: Acute Lung Injury (ALI), Biocontainment, High Consequence Pathogens, Interstitial Lung Disease, Pulmonary and Critical Care Medicine
Ariel R Green, MD, PhD, MPH
Expertise: Cognitive decline in older adults, dementia, general internal medicine, geriatric consultation and preventative health, geriatric medicine, polypharmacy, primary care of older adults
Jeremy Greene, MD, PhD, MA
Expertise: History of therapeutics, especially the pharmaceutical industry; history of medicine and global health
Craig Hendrix, MD
Expertise: Chemoprevention of HIV infection, topical HIV microbicides, clinical pharmacology of antiviral drugs, drug interactions
Janet Holbrook, PhD, MPH
Expertise: Design, conduct and analysis of multi-center clinical trials
Yoseob Joseph Hwang, MD, MSc
Expertise: Clinical epidemiology; pharmacoepidemiology; and outcomes research
John W. Jackson, ScD
Expertise: Development of methods to address healthcare disparities, development of methods to improve transparency and conduct of observational studies and post-hoc analyses of clinical trials
Sophie Lanzkron, MD, MHS
Expertise: Hematology, Sickle Cell Disease
Alan Lyles, ScD, MPH, BSPharm
Expertise: Public-, private- and third-sector arrangements, pharmaceutical economics and health policy, prevention and treatment of obesity, substance abuse and other lifestyle consequences
Seth Martin, MD, MHS
Expertise: Atherosclerosis, Cardiovascular Disease, Cardiovascular Risk Stratification, Chest Pain, Dyslipidemia, Preventive Cardiology, Risk Factor Modification
Meredith McCormack, MD, MHS
Expertise: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary and Critical Care Medicine
Hemalkumar Mehta, PhD
Expertise: Pharmaceutical health outcomes research
Erin Michos, MD, MHS
Expertise: Cardiovascular Disease, Heart Disease Prevention and Treatment in Women, Preventive Cardiology, Stress Testing, Transesophogeal Echocardiography (TEE), Vitamin D Deficiency
Brian J. Miller, MD, MBA, MPH
Expertise: FDA regulatory policy, payment policy, antitrust
Edgar Miller III, MD, PhD
Expertise: High Blood Pressure (Hypertension), Internal Medicine
Ramin Mojtabai, MD, PhD
Expertise: Pharmacoepidemiology of psychiatric drugs, mental health services research including trends and correlates of use of services, barriers to accessing services, process and outcome of treatments
Richard Moore, MD, MHS
Expertise: Pharmacoepidemiology, outcomes research in HIV treatment, epidemiology of substance abuse and alcoholism
Thomas J. Moore, AB
Expertise: Assessing risks of therapeutic drugs, design and interpretation of clinical trials, Food and Drug Administration regulation of drugs and biologics
Rakhi Naik, MD, MHS
Expertise: Bleeding Disorders, Hematology, Hemoglobinopathies, Myelodysplastic/Myeloproliferative Neoplasms, Thromboembolic Disease
Suzanne Nesbit, PharmD, BCPS
Expertise: Pain Management
Derek Ng, PhD
Expertise: epidemiologic methods; cohort studies; measurement; pediatric chronic kidney disease; pediatric critical care; extracorporeal membrane oxygenation; ECMO
Brent Petty, MD
Expertise: Clinical pharmocology
Ken Shermock, PharmD, PhD
Expertise: Medication safety and quality in the hospitalized setting
Jung-Im Shin, MD, PhD
Expertise: Cardiovascular and clinical epidemiology
Mariana Socal, MD, PhD
Expertise: Drug coverage, drug formularies, pharmaceutical policy
Elizabeth Stuart, PhD
Expertise: Statistical methodology for mental health research, particularly relating to causal inference and missing data
Ravi Varadhan, PhD, PhD
Expertise: Mathematical approaches for characterizing the homeostatic impairments underlying the geriatric syndrome of frailty; flexible regression modeling approaches for risk-factor etiology and prediction in observational studies of geriatric syndromes.
Joy Wan, MD, MSCE
Expertise: Clinical epidemiology and outcomes research in chronic skin diseases; pediatric dermatology; drug utilization.
Robert A. Wise, MD
Expertise: Chronic Obstructive Pulmonary Disease (COPD), Pulmonary and Critical Care Medicine